Truth boundary: this is a synthetic buyer-education and scoping memo. It is not legal, privacy, security, clinical, billing or procurement advice. It does not claim AICS has a US specialty clinic customer, signed BAA, HIPAA/SOC 2/HITRUST certification, patient outcome, appointment growth, no-show reduction, revenue, ROI, ranking, platform partnership or AI accuracy result.
Forwardable memo block
Decision to make: whether we should shortlist, demo or buy an AI receptionist / patient-access option for missed patient calls, front-desk backlog, scheduling requests, referral intake or after-hours coverage.
Allowed in first review: public vendor pages, blank workflows, redacted screenshots, role-level process descriptions, approved scripts, no-PHI call categories, owner-defined scoring criteria and unanswered question logs.
Not allowed in first review: PHI/ePHI, patient lists, appointment exports, call recordings, EHR/PMS credentials, production API keys, login sharing, signed BAA assumptions, unreviewed clinical routing, revenue claims or ROI promises.
Required adviser lanes: HIPAA/privacy, security, legal, clinical operations, billing, procurement and IT integration owners must approve regulated or production decisions before any implementation.
Evidence AICS can produce without PHI
- Vendor evidence request list for BAA, subprocessor, retention, recording and model-training boundaries.
- No-PHI route map showing where missed calls, callbacks, referrals and scheduling blockers become owner-visible tasks.
- Claim-control checklist that separates public promises from verified clinic evidence.
- Owner dashboard spec for unresolved queue age, stop rules, open adviser questions and next decision.
- Buyer-sendable shortlist memo that names gaps without ranking vendors or claiming superiority.
Stop rules before demos or integration
- No patient data, credentials, call recordings or EHR/PMS exports are shared during the first review.
- No compliance, BAA, appointment-growth, revenue, ROI or AI-accuracy claim is accepted without source evidence and adviser review.
- No autonomous handling is scoped for urgent, clinical, identity mismatch, billing dispute, complaint or consent-sensitive cases.
- No production vendor access is granted until owner, security and procurement lanes are named.
Use this before vendor spend
AICS can convert public pages and no-PHI workflow notes into a clinic-owned evidence packet before demos, integration work or risky data sharing.
Request no-PHI reviewRelated: AI receptionist vendor shortlist evidence matrix · HIPAA intake boundary checklist · More resources